Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cost-Effective Strategies in the Management of Advanced Colorectal Cancer

Cost-Effective Strategies in the Management of Advanced Colorectal Cancer After many years of fluorouracil being a standard part of various treatment regimens for patients with advanced or metastatic colorectal cancer, new agents are now available. The purchase costs of these novel agents are higher than for fluorouracil, so the question is whether these options are cost-effective. This review focuses on cost-effectiveness, concentrating mainly on the drug costs that constitute only a small percentage of the overall cost of cancer care, but are a major focus in the planning of healthcare services. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Cost-Effective Strategies in the Management of Advanced Colorectal Cancer

American Journal of Cancer , Volume 2 (2) – Aug 10, 2012

Loading next page...
 
/lp/springer-journals/cost-effective-strategies-in-the-management-of-advanced-colorectal-qog8mACn00

References (128)

Publisher
Springer Journals
Copyright
Copyright © 2003 by Adis Data Information BV
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200302020-00004
Publisher site
See Article on Publisher Site

Abstract

After many years of fluorouracil being a standard part of various treatment regimens for patients with advanced or metastatic colorectal cancer, new agents are now available. The purchase costs of these novel agents are higher than for fluorouracil, so the question is whether these options are cost-effective. This review focuses on cost-effectiveness, concentrating mainly on the drug costs that constitute only a small percentage of the overall cost of cancer care, but are a major focus in the planning of healthcare services.

Journal

American Journal of CancerSpringer Journals

Published: Aug 10, 2012

There are no references for this article.